Live Breaking News & Updates on Address unmet patient
Stay updated with breaking news from Address unmet patient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass. & BEIJING (BUSINESS WIRE) May 19, 2021 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical results and updates from its broad portfolio will be presented at the 2021 Annual Meeting of the American Society of Cancer Oncology (ASCO) being held June 4 â 8, 2021. âWe are pleased to share updates from our growing clinical portfolio across solid tumors and hematologic malignancies at this yearâs ASCO, including multiple novel combinations of tislelizumab with our investigational Fc-competent anti-TIGIT-antibody ociperlimab and other therapeutic agents, and the ongoing evaluation of our next-generation BTK inhibitor zanubrutinib,â commented Lai Wang, Ph.D., Global Head of R&D at BeiGene. âWe believe that these presentations underscore the breadth and diversity, as well as the remarkable progress and momentum, in B ....